Earnings Call · Q3 FY2022·2022-11-01

Q3 22EPS +27.14%·Rev n/aQ2 22EPS +14.61%·Rev n/aQ1 22EPS +3.18%·Rev n/aQ4 21EPS +24.14%·Rev n/a⚠ consensus missing

PFIZER INC PFE

Christopher Stevo — Senior Vice President and Chief Investor Relations Officer

Albert Bourla — Chairman and Chief Executive Officer

David Denton — Chief Financial Officer

Mikael Dolsten — President, Worldwide Research and Development and Medical

+3.1%1d on move date+3.6% vs SPY3d+0.9%5d+2.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PFE calls or request research access.

More PFE calls Browse calls Request research access